enhancer in the treatment of neurodegenerative diseases. As part of this research, a series of alkoxylated 6H-benzo[c]chromen-6-one derivatives were designed and synthesized. Furthermore, their biological activities were evaluated as potential PDE2 inhibitors, and the alkoxylated 6H-benzo[c]chromen-6-one derivative 1f was found to have the optimal inhibitory potential (IC50: 3.67 ± 0.47 μM). It also exhibited
尿石素(羟基化的6 H-苯并[ c ] chromen-6-ones)是
鞣花酸(EA)的主要
生物利用代谢物,被证明是治疗神经退行性疾病的认知增强剂。作为本研究的一部分,设计并合成了一系列烷氧基化的6 H-苯并[ c ] chromen-6-one衍
生物。此外,评估了它们的
生物活性作为潜在的PDE2
抑制剂,发现烷氧基化的6 H-苯并[ c ] chromen-6-one衍
生物1f具有最佳的抑制潜力(IC 50:3.67±0.47μM)。与BAY 60-7550体外细胞
水平研究相比,它还表现出可比的活性。